Medical treatment for rheumatic diseases

Area of Science:

• Rheumatology and Internal Medicine
• Pharmacology and Therapeutics

Background:

• Rheumatoid arthritis (RA) is a chronic inflammatory disorder requiring comprehensive management strategies.
• Patient care necessitates a multidisciplinary team approach, integrating various therapeutic modalities.
• Physician initiative is crucial for coordinating care and implementing treatment plans.

Purpose of the Study:

• To outline the essential components of rheumatoid arthritis management.
• To discuss the role of pharmacotherapy, including analgesics, NSAIDs, and disease-modifying antirheumatic drugs (DMARDs).
• To emphasize the importance of balancing treatment efficacy with potential adverse effects.

Main Methods:

• Review of current therapeutic strategies for rheumatoid arthritis.
• Discussion of pharmacological interventions for early and advanced disease stages.
• Consideration of non-pharmacological interventions such as physiotherapy and patient education.

Main Results:

• Non-drug therapies like rest, physiotherapy, and patient education are vital alongside medical treatments.
• Analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) manage early RA symptoms (pain, stiffness).
• Advanced RA may require second-line DMARDs (e.g., methotrexate, gold, penicillamine, antimalarials, sulphasalazine), involving risk-benefit assessment.

Conclusions:

• Comprehensive rheumatoid arthritis management integrates drug therapy, non-drug interventions, and patient support.
• Careful selection and monitoring of medications are essential due to potential side effects.
• Intra-articular treatments and surgical collaboration between rheumatologists and orthopaedic surgeons offer localized solutions.